Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Non-Current Deferred Tax Liability (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 5 years of Non-Current Deferred Tax Liability data on record, last reported at $2.0 million in Q2 2025.

  • For Q2 2025, Non-Current Deferred Tax Liability changed N/A year-over-year to $2.0 million; the TTM value through Jun 2025 reached $2.0 million, changed N/A, while the annual FY2024 figure was $11000.0, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability reached $2.0 million in Q2 2025 per MRVI's latest filing, up from $2.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $8.7 million in Q1 2023 and bottomed at $11000.0 in Q4 2024.
  • Average Non-Current Deferred Tax Liability over 4 years is $5.2 million, with a median of $6.7 million recorded in 2023.